Perrigo Company plc (PRGO)
Largest Insider Buys in Sector
PRGO Stock Price History Chart
PRGO Stock Performance
About Perrigo Company plc
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, …
Insider Activity of Perrigo Company plc
Over the last 12 months, insiders at Perrigo Company plc have bought $725,878 and sold $1.6M worth of Perrigo Company plc stock.
On average, over the past 5 years, insiders at Perrigo Company plc have bought $1.49M and sold $2.11M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Willis Robert (EVP & CHRO) — $337,083. Lockwood-Taylor Patrick (CEO) — $252,168. Ives Alison (EVP & Chief Scientific Officer) — $108,727.
The last purchase of 1,000 shares for transaction amount of $27,900 was made by Andersen Svend (EVP & President CHCI) on 2024‑05‑28.
List of Insider Buy and Sell Transactions, Perrigo Company plc
| 2024-09-13 | Sale | director | 8,954 0.0065% | $27.30 | $244,444 | -6.85% | ||
| 2024-08-26 | Sale | EVP, Gbl Ops & SC & CTO | 13,000 0.0096% | $29.40 | $382,246 | -8.90% | ||
| 2024-08-20 | Sale | EVP & President CHCI | 34,983 0.0255% | $27.69 | $968,560 | -3.60% | ||
| 2024-05-28 | EVP & President CHCI | 1,000 0.0007% | $27.90 | $27,900 | -0.73% | |||
| 2024-03-05 | EVP & Chief Scientific Officer | 2,490 0.0018% | $27.26 | $67,877 | +2.97% | |||
| 2024-03-01 | EVP & CHRO | 371 0.0003% | $26.30 | $9,757 | +6.42% | |||
| 2024-02-29 | EVP & CHRO | 6,000 0.0043% | $25.87 | $155,220 | +6.66% | |||
| 2024-02-29 | CEO | 9,500 0.0071% | $26.54 | $252,168 | +6.66% | |||
| 2024-02-29 | EVP & Chief Scientific Officer | 1,545 0.0011% | $26.44 | $40,850 | +6.66% | |||
| 2023-11-24 | EVP & CHRO | 5,550 0.0041% | $31.01 | $172,106 | -4.18% | |||
| 2023-11-16 | EVP & Chief Scientific Officer | 2,040 0.0015% | $29.34 | $59,854 | +1.96% | |||
| 2023-11-14 | CEO | 11,000 0.0082% | $28.99 | $318,868 | +3.14% | |||
| 2023-11-14 | EVP & Chief Financial Officer | 5,000 0.0037% | $29.18 | $145,882 | +3.14% | |||
| 2023-06-13 | director | 10,000 0.0074% | $33.06 | $330,637 | -4.62% | |||
| 2023-05-23 | EVP & President CHCI | 2,900 0.0022% | $33.41 | $96,902 | -2.60% | |||
| 2023-05-11 | Sale | CEO | 197,646 0.1476% | $35.75 | $7.07M | -8.77% | ||
| 2023-03-13 | Sale | EVP and CIO | 3,723 0.0028% | $35.57 | $132,435 | -5.40% | ||
| 2023-03-10 | Sale | EVP & President CSCA | 9,000 0.0066% | $35.70 | $321,309 | -6.85% | ||
| 2023-03-08 | Sale | EVP, Gbl Ops & SC & CTO | 4,500 0.0033% | $36.92 | $166,133 | -9.18% | ||
| 2023-03-06 | director | 5,000 0.0038% | $38.05 | $190,270 | -8.74% |
Insider Historical Profitability
| Willis Robert | EVP & CHRO | 25476 0.0187% | $27.98 | 3 | 0 | |
| Lockwood-Taylor Patrick | CEO | 20500 0.015% | $27.98 | 2 | 0 | |
| Ives Alison | EVP & Chief Scientific Officer | 16122 0.0118% | $27.98 | 3 | 0 | |
| Andersen Svend | EVP & President CHCI | 7000 0.0051% | $27.98 | 6 | 1 | <0.0001% |
| Smith Jeffrey C | director | 3662220 2.6844% | $27.98 | 3 | 0 | <0.0001% |
Institutional Investor Ownership
| The Vanguard Group | $480.18M | 10.94 | 14.92M | -0.52% | -$2.49M | 0.01 | |
| BlackRock | $420.42M | 9.58 | 13.06M | -2.12% | -$9.1M | 0.01 | |
| Dimensional Fund Advisors | $222.53M | 5.07 | 6.91M | +10.13% | +$20.46M | 0.06 | |
| State Street | $218.53M | 4.98 | 6.79M | +48.9% | +$71.77M | 0.01 | |
| DePrince, Race & Zollo, Inc. | $112.37M | 2.56 | 3.49M | +26.01% | +$23.19M | 2.42 |